To further investigate the involvement of hepcidin in iron metabolism disorders and anemia in the SDS mice, we administered dalteparin, a known hepcidin inhibitor, to the mice and examined its ameliorative effects. This evidence concerns the gene HAMP and iron metabolism disease.